0000899243-21-036769.txt : 20210921 0000899243-21-036769.hdr.sgml : 20210921 20210921160518 ACCESSION NUMBER: 0000899243-21-036769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210917 FILED AS OF DATE: 20210921 DATE AS OF CHANGE: 20210921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: A2A Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001859061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40335 FILM NUMBER: 211266463 BUSINESS ADDRESS: STREET 1: 544 KING STREET CITY: CHAPPAQUA STATE: NY ZIP: 10514 BUSINESS PHONE: (914) 841-8818 MAIL ADDRESS: STREET 1: 544 KING STREET CITY: CHAPPAQUA STATE: NY ZIP: 10514 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biomea Fusion, Inc. CENTRAL INDEX KEY: 0001840439 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 726 MAIN STREET CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: (650) 980-9099 MAIL ADDRESS: STREET 1: 726 MAIN STREET CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-17 0 0001840439 Biomea Fusion, Inc. BMEA 0001859061 A2A Pharmaceuticals, Inc. C/O BIOMEA FUSION, INC. 726 MAIN STREET REDWOOD CITY CA 94063 0 0 1 0 Common Stock 2021-09-17 4 P 0 34658 10.96 A 4400000 D The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.89 to $11.04. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are held directly by A2A Pharmaceuticals Inc. Sotirios Stergiopoulos is a member of the Issuer's Board of Directors and is an affiliate of the Reporting Person. /s/ Sotirios Stergiopoulos, CEO 2021-09-21